HIRONC

The event introduced two next-generation devices: an advanced contouring and face lifting platform powered by microwave technology, available for export as MIGLOU™, and a revolutionary needle-free injector that uniquely combines three technologies — micro-jetting, electroporation, and plasma — in a single platform, available for export as SYNERJET PRO™.

The launch was enriched by four in-depth lectures delivered by four of Korea's foremost aesthetic experts, offering clinical insights, hands-on perspectives, and forward-looking analysis on both devices and the broader direction of non-invasive aesthetics.

Across the presentations, experts consistently highlighted what sets HIRONIC apart in a crowded market. HIRONIC devices are recognized for their exceptional build quality, and the brand has remained steadfastly focused on non-invasive technologies — always prioritizing reduced patient discomfort alongside improved clinical efficacy. It is this unwavering philosophy, experts noted, that allows HIRONIC devices to consistently outperform competitors.

On the microwave contouring device, experts drew particular attention to its proprietary FIM (Focused Intensive Microwave) technology — a uniquely advanced feature that enhances treatment efficiency while delivering the same energy output. This innovation, experts emphasized, is an entirely distinctive advancement that elevates MIGLOU™ (export name) to true second-generation microwave technology status, setting it apart from all currently available solutions and creating clear, immediate market value.

Regarding the triple-technology needle-free injector, experts were equally emphatic: combining micro-jetting, electroporation, and plasma into a single device is not incremental progress — it is a meaningful leap forward. When these three technologies work in synergy, they significantly enhance active ingredient absorption, a benefit now supported by recent clinical studies. Experts underscored that SYNERJET PRO™ (export name) directly overcomes the limitations of currently available needle-free solutions, positioning it as an undeniable step toward shifting the aesthetics industry from the injection era into a new age of advanced needle-free delivery.

The private launch preview was more than a product reveal — it was a statement of direction. With two devices that each advance their respective categories in meaningful, clinically relevant ways, HIRONIC once again demonstrated its commitment to pushing the boundaries of non-invasive aesthetics. As both platforms make their way to markets worldwide, the industry will be watching closely — and if the response from Korea and Japan's top experts is any indication, the impact is set to be significant.​